Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C0NH
|
||||
| Former ID |
DCL000443
|
||||
| Drug Name |
Avastin+/-Tarceva
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Non-small cell lung cancer [ICD10:C33-C34] | Phase 3 | [1] | ||
| Company |
Genentech
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C10H6O3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor | Target Info | Inhibitor | [2], [3] | |
| References | |||||
| REF 1 | Clinical pipeline report, company report or official report of Roche. | ||||
| REF 2 | Clinical pipeline report, company report or official report of Genentech (2009). | ||||
| REF 3 | Clinical pipeline report, company report or official report of Genentech (2009). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.